MONMOUTH JUNCTION, N.J., March 2, 2017 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using blood purification to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced that its Chief Financial Officer, Kathleen Bloch, will present at the 37th Annual Cowen and Company Healthcare Conference on Wednesday, March 8, 2017 at 10:40AM ET in Boston, MA.